Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth

Edelsohn, G. A.,
Karpov, I.,
Parthasarathy, M.,
Hutchison, S. L.,
Castelnovo, K.,
Ghuman, J.,
Schuster, J. M.
Year Published: 2017
Journal Article
Journal Name: 
Journal of the American Academy of Child and Adolescent Psychiatry
Volume: 56

Issue: 1

These authors examined trends in the use of antipsychotic medication among Medicaid-eligible youth aged 0 to 17 from 2008 to 2013, and the factors associated with this use. Demographic and clinical variables were derived from state eligibility data and service claims data from a behavioral health managed care organization (BHMCO). The overall trend in prevalence for antipsychotics for youth decreased from 49.52 per 1,000 members in 2008 to 30.54 in 2013. Although rates decreased for all age groups, the youngest children (0-5 years) had the largest decrease. Rates were higher for males compared to females regardless of age. Children with a diagnosis of attention-deficit/hyperactivity disorder were less likely to be prescribed antipsychotics than those with diagnoses of autism spectrum disorder, bipolar disorder, psychoses, or depression. The authors discuss the clinical, policy, and managed care implications of their findings. Modified Author Abstract.

Copyright Protected
9-5 pm Eastern